Abstract

BackgroundGSK3β is involved in a wide range of physiological functions, and is presumed to act in the pathogenesis of neurological diseases, from bipolar disorder to Alzheimer’s disease (AD). In contrast, the GSK3α isozyme remained largely ignored with respect to both aspects.ResultsWe generated and characterized two mouse strains with neuron-specific or with total GSK3α deficiency. Behavioral and electrophysiological analysis demonstrated the physiological importance of neuronal GSK3α, with GSK3β not compensating for impaired cognition and reduced LTP. Interestingly, the passive inhibitory avoidance task proved to modulate the phosphorylation status of both GSK3 isozymes in wild-type mice, further implying both to function in cognition. Moreover, GSK3α contributed to the neuronal architecture of the hippocampal CA1 sub-region that is most vulnerable in AD. Consequently, practically all parameters and characteristics indicated that both GSK3 isoforms were regulated independently, but that they acted on the same physiological functions in learning and memory, in mobility and in behavior.ConclusionsGSK3α proved to be regulated independently from GSK3β, and to exert non-redundant physiological neurological functions in general behavior and in cognition. Moreover, GSK3α contributes to the pathological phosphorylation of protein Tau.

Highlights

  • GSK3β is involved in a wide range of physiological functions, and is presumed to act in the pathogenesis of neurological diseases, from bipolar disorder to Alzheimer’s disease (AD)

  • GSK3β was proposed as a therapeutic target based on the treatment of bipolar disorder with lithium salts, but this seriously suffers from limited effectiveness, narrow therapeutic window and side-effects

  • Generation of two mouse strains with either neuronspecific or with total deficiency of GSK3α To define the physiological functions of GSK3α in adult brain in vivo, we aimed in first instance to generate mice with a conditional, post-natal and neuron-specific deficiency of GSK3α by the Cre-Lox system

Read more

Summary

Introduction

GSK3β is involved in a wide range of physiological functions, and is presumed to act in the pathogenesis of neurological diseases, from bipolar disorder to Alzheimer’s disease (AD). Glycogen synthase kinase-3 (GSK3) comprises two structurally and functionally related serine-threonine kinases, active in many physiological processes [1,2,3,4,5]. Both are inherently active and controlled by phosphorylation at two levels: (i) inhibitory phosphorylation of serine residues S21/S9 in GSK3α/β and (ii) tyrosine phosphorylation at Y279/Y216 in GSK3α/β, which augments their activity and relieves substrate-priming by other kinases [6,7]. Pre-synaptically, GSK3 controls activity-dependent bulk endocytosis [18,19]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call